Restoring facial fullness after GLP-1 weight loss with Radiesse
Part of Skin clinical trials.
This trial tests whether a facial filler called Radiesse can restore volume lost during weight loss from GLP-1 medications (like Wegovy or Mounjaro). It's for adults just starting GLP-1 therapy who expect to lose 20 pounds or more and want to see if fillers can help their face look fuller.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old.
- You are just starting a GLP-1 medication (like semaglutide or tirzepatide) for weight loss or diabetes weight management and plan to lose at least 20 pounds.
- Your body mass index (BMI) is between 24 and 32.
- You have enough facial fat (your face is not already very hollow) and are willing to get facial filler injections.
- You have not had any facial cosmetic procedures in the last 2 years (like fillers, fat transfer, or lifts) or certain treatments in the last year or 4 months.
- You do not have severe acne, psoriasis, or scars on your face, and you are not allergic to calcium hydroxylapatite (Radiesse) or lidocaine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a hyaluronic acid filler (a common wrinkle-smoothing treatment) can improve skin quality in women who are taking GLP-1 medications for weight or diabetes. It aims to see if the filler can help with common skin changes like loss of firmness and wrinkles.
This study tests a skin serum to improve facial aging signs like fine lines and dullness. It is for post-menopausal women aged 45-65 who are taking a GLP-1 medication (e.g., Ozempic, Wegovy).
This study tests a topical serum to improve visible signs of facial aging in people who are currently taking a GLP-1 medication. If you qualify, you'll use the serum for the study period and see if it helps with fine lines, sagging, and skin texture.
This trial tests whether PLLA injections can safely improve facial sagging in people who lost weight on GLP-1 drugs. If you are between 30 and 60, have noticeable sagging or smile lines, and have not had other facial treatments recently, this may be an option.
This study tests two types of injectable fillers, PLLA and CaHA-R, to improve skin texture and tightness in the cheeks and chest area. It may be a good option for women looking to treat mild to severe skin irregularities.
This study tests a new device that processes your own fat (taken from your body) to use for facial fat grafting, which may help improve facial contours or volume. It is for people who are interested in using their own fat for facial rejuvenation and are willing to avoid other facial cosmetic procedures during the study.
Hear when a new Volume Loss (Soft Tissue Ptosis or Atrophy ) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.